ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0490

Analysis of Emergency Department Visits by Patients with Giant Cell Arteritis: A National Population-based Study

Ehizogie Edigin1, Amy Trang2, Chinenye Osuorji3, Solomon Anighoro4, Precious Eseaton5, Christopher Hino1, Osahon Idolor6, Nneka Chukwu7, Anum Akhlaq8 and Mehrnaz Hojjati1, 1Loma Linda University Health, Loma Linda, CA, 2Rush University Medical Center, Chicago, IL, 3Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY, 4St. Helens and Knowsley Teaching hospitals NHS Trust, Prescot, England, United Kingdom, 5University of South Wales, Cardiff, Wales, United Kingdom, 6Piedmont Athens Regional, Atlanta, GA, 7Nuvance Health, Poughkeepsie, 8University of Mississippi Medical Center, Jackson, MS

Meeting: ACR Convergence 2022

Keywords: giant cell arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Vasculitis – Non-ANCA-Associated and Related Disorders Poster I: Giant Cell Arteritis

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Giant Cell Arteritis (GCA) is the most common vasculitis in patients older than 50 years of age. GCA has significant economic burden and increases health care utilization such as Emergency Department (ED) visits and hospitalization. There is scarcity of large national level data on the reasons for presentation to the ED among patients with GCA in the United States (US). This study aims to outline the most common reasons for ED presentation among patients with GCA. We also aim to study baseline demographic characteristics, ED outcomes among patients who presented to the ED principally due to GCA.

Methods: We obtained data from the National Emergency Department Sample (NEDS) 2018 database. The NEDS is the largest publicly available ED database in the US. The NEDS is a nationally representative stratified sample of 20% of US hospital owned EDs. The 2018 NEDS contains about 35.8 million unweighted ED visits, which is roughly estimated to be about 143 million ED visits. Each ED visit in the NEDS has a principal diagnosis (the main reason for the visit) and can have up to 34 secondary diagnoses (any other diagnosis other than the principal diagnosis). We searched for ED visits for adult patients aged ≥50, with any (i.e either principal or secondary) diagnosis of GCA using ICD-10 codes “M315” or “M316”. STATA, version 16 was used for analysis. By using a “rank” command in STATA, the most common principal discharge diagnoses were divided into categories based on organ system, and the most common specific principal discharge diagnoses were recorded for ED visits among patients with any diagnosis of GCA in descending order of frequency. We then outlined baseline demographic characteristics and ED visit outcomes of patients who presented to the ED with a principal diagnosis of GCA.

Results: Out of 143 million ED visits in 2018, 20,886 (0.015%) of these visits were for patients with GCA. Rheumatologic, cardiovascular (CV), infections and respiratory were the most common reasons for presentation to the ED for patients with GCA. GCA, headaches, infectious etiologies such as sepsis, pneumonia, urinary tract infections and hypertensive heart disease with chronic kidney disease and heart failure were the most common specific principal discharge diagnosis of GCA patients who presented to the ED. See Table 1 and Figure 1Among GCA patients who presented to the ED, 3888 of these visits were principally because of GCA. ED visits principally because of GCA were predominantly elderly (mean age of 73 years), females (67.7%), admitted (59.2%), Medicare insured (77.2%), charlson comorbidity index score of less than 3 (78.4%) and presented to metropolitan teaching hospitals in the south. See Table 2.

Conclusion: GCA patients are most likely to present to the ED due to their underlying GCA. Infections and CV are also common reasons for presentation to the ED. GCA patients who presented to the ED principally due to GCA are most likely to be elderly white females and admitted. Optimizing management of GCA and its comorbidities, measures for prevention and early detection of infections while on immunosuppressants in the outpatient setting are important in preventing ED visits and hospital admissions of GCA patients.

Supporting image 1

Table 1: ICD_10 code categories and specific principal discharge diagnosis for Emergency Department visit of patients with Giant Cell Arteritis.

For emergency department visits of patients with any (i.e either principal or secondary) diagnosis of Giant Cell Arteritis.
COPD: Chronic obstructive pulmonary disease

Supporting image 2

Table 2: Baseline characteristics of patients who presented to the Emergency Department principally due to Giant Cell Arteritis in the United States in 2018.
Abbreviations: * Emergency department visits for patients aged ≥ 50 years with Giant Cell Arteritis as the “principal” diagnosis, LOS: Length of inpatient stay for those admitted, Charge: charge for Emergency department visit, USD: United States dollars, income** Median household income national quartile for patient’s Zip code, SNF: Skilled nursing facility, COPD: Chronic obstruction pulmonary disease

Supporting image 3

Figure 1: Pareto chart of ICD_10 code categories in descending order of frequency for Emergency Department visit of patients with Giant Cell Arteritis. Line on the secondary axis plots the cumulative percentages of each ICD_10 code categories

Abbreviations: Hema/Onc: Neoplasms & diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism, Endo: Endocrine, nutritional and metabolic diseases, Psych: Mental, behavioral and neurodevelopmental disorders, Neuro: Diseases of the nervous system, CVS: Diseases of the circulatory system, Respiratory: Diseases of the respiratory system, GI: Diseases of the digestive system, Rheum: Diseases of the musculoskeletal system and connective tissue, GU: Diseases of the genitourinary system, others: Symptoms, signs, and abnormal clinical laboratory findings, not elsewhere classified, Health services: Factors influencing health status and contact with health services


Disclosures: E. Edigin, None; A. Trang, None; C. Osuorji, None; S. Anighoro, None; P. Eseaton, None; C. Hino, None; O. Idolor, None; N. Chukwu, None; A. Akhlaq, None; M. Hojjati, None.

To cite this abstract in AMA style:

Edigin E, Trang A, Osuorji C, Anighoro S, Eseaton P, Hino C, Idolor O, Chukwu N, Akhlaq A, Hojjati M. Analysis of Emergency Department Visits by Patients with Giant Cell Arteritis: A National Population-based Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/analysis-of-emergency-department-visits-by-patients-with-giant-cell-arteritis-a-national-population-based-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/analysis-of-emergency-department-visits-by-patients-with-giant-cell-arteritis-a-national-population-based-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology